by Michael Persons | Oct 20, 2020 | Uncategorized
News & Events News Clone This to Start a News Post Experienced commercial leader solidifies Company’s management team as it integrates novel therapies with innovative drug delivery Sed ut perspiciatis, unde omnis iste natus error sit voluptatem accusantium doloremque...
by Michael Persons | Aug 3, 2020 | News, News-2020
News & Events News TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9...
by Michael Persons | Jun 1, 2020 | News, News-2020
News & Events News TriSalus Appoints Rajesh B. Mistry Chief Financial Officer June 1, 2020–TriSalus Life Sciences (“TriSalus”), a company committed to transforming outcomes for patients with solid tumors, today announced the appointment of Rajesh B. Mistry as Chief...
Recent Comments